Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids

Completed · Phase 2

Conditions studied: Opioid-Related Disorders

In brief

Opioids used to treat chronic pain have a high abuse potential. The purpose of this study is to determine the effectiveness of buprenorphine in treating opioid dependent individuals who abuse opioids that are prescribed for chronic pain.

Key facts

Study ID

NCT00218101

Run by

National Institute on Drug Abuse (NIDA)

People needed

10

Starts

2004-05-01

Expected to finish

2005-03-01

Last updated by the study team

2017-01-12

Who can join

Age: 25 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Current opioid analgesic dependence
• History of at least 2 years of oral opiate analgesic use
• Prescribed opioids for chronic pain
• Pain episode of at least 6 months duration within the 5 years prior to study entry
• Available for the duration of the study
• Good general health

You may not qualify if…

• Currently using any illicit substance
• Meets criteria for alcohol dependence
• History of heroin use
• History of opiate replacement therapy, including Levo-Alpha Acetyl Methadol (LAAM) or methadone
• Evidence of current maximal primary pain

Where it is running

• University of Texas Health Science Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.